Experimental Word Learning in Children With and Without Language Impairment
NCT ID: NCT00607334
Last Updated: 2008-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
51 participants
INTERVENTIONAL
2003-07-31
2007-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Manipulating Linguistic Complexity to Improve Child Language Treatment Outcomes
NCT03977701
Retrieval-Based Word Learning in Autistic Children
NCT06466876
Predicting Language and Literacy Growth in Children With ASD Using Statistical Learning
NCT06332144
The Effect of Prior Learning on Word Learning
NCT05921188
Effect of Word Characteristics and Orthography on Vocabulary Learning
NCT06935851
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GP
Children with Developmental Language Impairments were enrolled in this group.
Word-learning
Exposure to five nonwords for three sessions of controlled interaction with the experimenter
GC
Children with normal language development were enrolled in this group.
Word-learning
Exposure to five nonwords for three sessions of controlled interaction with the experimenter
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Word-learning
Exposure to five nonwords for three sessions of controlled interaction with the experimenter
Word-learning
Exposure to five nonwords for three sessions of controlled interaction with the experimenter
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* enrolled in language therapy
* age between 3:0 (years:months) and 3:11
* For GC subjects: - normal performance in a language screening procedure
* normal performance in an expressive vocabulary test
Exclusion Criteria
* diagnosed neurological or behavioral conditions
* major cognitive impairment
* For GC subjects: - communication complaints from caregivers
* history of previous enrollment in language therapy
36 Months
47 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Sao Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of São Paulo
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Debora M. Befi-Lopes, PhD
Role: STUDY_CHAIR
University of Sao Paulo
Juliana P. Gândara, PhD student
Role: PRINCIPAL_INVESTIGATOR
University of Sao Paulo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
USP - Faculty of Medicine - Department of Physiotherapy, Communication Sciences and Disorders, Occupational Therapy
São Paulo, São Paulo, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
24061316
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.